Part of the prophylactic armoury against pandemic disease is a programme of surveillance for emergent pathogens. The current SARSCoV-2 outbreak may have been foreseeable as …

Under new leadership, the US Food and Drug Administration (FDA) is now focusing efforts on closing the gap between scientific advances and the computing solutions …

With the rapidly evolving nature of the coronavirus (COVID-19) pandemic, configurability and adaptability are key for IRT systems in order to minimise the impact to …

The FDA has created a special emergency programme for therapeutics known as the Coronavirus Treatment Acceleration Program (CTAP). This programme attempts to utilise all available …

COVID-19 is a new virus with its own characteristics and the human population has showed its naivety. The number of individuals infected with COVID-19 continues …

The definition of being truly patient-centric is simply allowing a patient to participate in a clinical trial with minimal disruption to their personal and family …

Whilst pandemics are fortunately not common, the global impact of COVID-19 has been profound. At the time of writing, global deaths havereached 420,000 whilst over …

Employing Adaptive Approaches to Reach Desired Clinical Objectives The field of oncology is expanding and changing rapidly. With increasing advancements in genomics and interests in …

The World Health Organization (WHO) classification system for obesity is based on body mass index (BMI). A BMI of 25.0 to 29.9 kg/ m2 is …

Lung cancer is the leading cause of cancer death – 1.76 million lung cancer deaths occurred worldwide in 2018. More than 80% of patientswere presenting …